About
Noninvasix will be the first company to monitor the severity of sepsis and septic shock non-invasively, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real time. Incorporating Noninvasix into the ICU workflow allows clinicians to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes. Future developments, enhancements, and evidence will expand our technology's use and clinical impact in other indications and settings. Noninvasix is backed by 15 years of optoacoustic research and more than $6.5 million in research grants.
Technologies
Gmail
Google Apps
MailChimp SPF
Microsoft Office 365
Google Cloud Hosting
Mobile Friendly
Typekit
Google Font API
reCAPTCHA
WordPress.org
Google Tag Manager
Nginx
Android
Python
Remote
SharePoint
Basis
Circle
Flutter
Keywords
medical devices
optoacoustics
patient monitoring
oximetry
critical care
intensive care medicine
critical care medicine
sepsis
septic shock
patient safety
medtech
oxygen saturation
venous saturation
emergency medicine
ventures for good
diagnostics
medical
health care
medical equipment manufacturing
real-time tissue hypoxia monitoring
sepsis treatment
septic shock monitoring
central venous saturation
optical platform
blood oxygen saturation
optical sensor technology
livox monitor
icu patient care
medical device development
non-invasive technology
Company Information
-
Employees 3
-
Founded 2007
-
Annual Revenue $3000000
-
Total Funding $5580732
Location
1700 The Strand, Galveston, Texas, United States, 77550
